What is he best known for?
The fields of study he is best known for:
- Cancer
- Gene
- Internal medicine
His primary areas of investigation include Cancer research, Drug resistance, Cancer, Tubulin and Pharmacology.
His Cancer research research incorporates themes from Cell culture, ATP-binding cassette transporter, Phosphorylation, Tumor suppressor gene and Programmed cell death.
His study in the fields of Multiple drug resistance under the domain of Drug resistance overlaps with other disciplines such as Epigenesis.
His Cancer study combines topics from a wide range of disciplines, such as Microrna profiling, Gene expression profiling, Malignancy and microRNA.
The study incorporates disciplines such as Molecular biology, Epothilones and Paclitaxel in addition to Tubulin.
His study in Pharmacology is interdisciplinary in nature, drawing from both P-glycoprotein and Chemotherapy.
His most cited work include:
- Multidrug resistance in cancer: role of ATP-dependent transporters. (4031 citations)
- Tumour stem cells and drug resistance (2838 citations)
- An Information-Intensive Approach to the Molecular Pharmacology of Cancer (1049 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Oncology, Cancer research, Cancer and Pharmacology.
Tito Fojo interconnects Endocrinology, Surgery and Pathology in the investigation of issues within Internal medicine.
His Cancer research research is multidisciplinary, relying on both Cell culture, Multiple drug resistance, Drug resistance, Cancer cell and Microtubule.
His research on Drug resistance frequently links to adjacent areas such as Drug.
He has researched Cancer in several fields, including Gene and Immunology.
His Pharmacology research incorporates elements of Vinblastine, Paclitaxel, Chemotherapy and P-glycoprotein.
He most often published in these fields:
- Internal medicine (33.08%)
- Oncology (25.19%)
- Cancer research (23.31%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (33.08%)
- Oncology (25.19%)
- Cancer (21.80%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Oncology, Cancer, Cancer research and Hazard ratio.
His Internal medicine study incorporates themes from Paraganglioma and Pathology.
The various areas that Tito Fojo examines in his Oncology study include Regimen, Breast cancer, Prostate cancer and Cisplatin.
His research in Cancer intersects with topics in Clinical trial, Gene, Adrenocortical carcinoma and Intensive care medicine.
The Cancer research study combines topics in areas such as STK11, Loss function, Drug resistance and Carcinogenesis.
His work on Multiple drug resistance as part of general Drug resistance study is frequently connected to In patient, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
Between 2015 and 2021, his most popular works were:
- Precision oncology: origins, optimism, and potential (112 citations)
- Do patient access schemes for high-cost cancer drugs deliver value to society?-lessons from the NHS Cancer Drugs Fund (61 citations)
- The evidence framework for precision cancer medicine (56 citations)
In his most recent research, the most cited papers focused on:
Tito Fojo mostly deals with Internal medicine, Oncology, Cancer, Intensive care medicine and MEDLINE.
Head and neck squamous-cell carcinoma, Neutropenia, Chemoradiotherapy, Proportional hazards model and Chemotherapy are among the areas of Internal medicine where Tito Fojo concentrates his study.
In his study, Discontinuation is inextricably linked to Clinical trial, which falls within the broad field of Oncology.
His Intensive care medicine study frequently draws connections between related disciplines such as Pharmacology.
His Pharmacology study often links to related topics such as Bevacizumab.
His MEDLINE study which covers Precision medicine that intersects with Cancer genome, Medical prescription, Clinical significance, Cancer Medicine and Targeted therapy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
